Half-year report · Q2
7747.TEDINET S100V8NQ
Period2024-07-01 → 2024-12-31
Filed2025-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥61.5bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥107.5bn | 2023-07-01 → 2024-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥54.3bn | 2023-07-01 → 2023-12-31 | Cons. | Net sales |
| Operating income | ¥17.4bn | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Operating income | ¥13.5bn | 2023-07-01 → 2023-12-31 | Cons. | Operating income |
| Ordinary income | ¥16.8bn | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥22.0bn | 2023-07-01 → 2024-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.5bn | 2023-07-01 → 2023-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥16.9bn | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥13.4bn | 2023-07-01 → 2023-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥12.3bn | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥15.8bn | 2023-07-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥9.8bn | 2023-07-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥12.3bn | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Net income | ¥9.9bn | 2023-07-01 → 2023-12-31 | Cons. | Profit loss |
| Total assets | ¥190.1bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥191.6bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥169.1bn | at 2023-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥31.2bn | at 2024-12-31 | Cons. | Liabilities |
| Total liabilities | ¥39.7bn | at 2024-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥158.9bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥152.0bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥138.8bn | at 2023-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥37.6bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥35.7bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥37.6bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥35.7bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥32.5bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥34.9bn | at 2023-06-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥18.3bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥34.7bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥12.6bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥7.0bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥21.2bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.0bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥8.9bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥13.9bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥11.8bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥45.14 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥58.2 | 2023-07-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥36.15 | 2023-07-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 83.2% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.9% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 81.6% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2024-12-31 | −¥7.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2024-12-31 | −¥7.3bn |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2024-12-31 | −¥3.6bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥13.0bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥5.7bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥7.3bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥2.5bn |
| jpcrp040300-q2r_E02349-000Medicalreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥55.8bn |
| jpcrp040300-q2r_E02349-000Medicalreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥55.8bn |
| jpcrp040300-q2r_E02349-000Medicalreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥18.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-07-01 → 2024-12-31 | ¥68.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-07-01 → 2024-12-31 | ¥61.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥7.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-07-01 → 2024-12-31 | ¥21.0bn |
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2023-12-31 | −¥6.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2023-12-31 | −¥6.8bn |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2023-12-31 | −¥3.4bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥12.7bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥6.0bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥6.8bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥2.9bn |
| jpcrp040300-q2r_E02349-000Medicalreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥48.4bn |
| jpcrp040300-q2r_E02349-000Medicalreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥48.4bn |
| jpcrp040300-q2r_E02349-000Medicalreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥14.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-07-01 → 2023-12-31 | ¥61.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-07-01 → 2023-12-31 | ¥54.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥6.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-07-01 → 2023-12-31 | ¥16.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 478
| Item | Context | Value | Unit |
|---|---|---|---|
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -120000000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -4622000000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -3933000000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -5533000000 | JPY |
| Payments from changes in ownership interests in subsidiaries that do not result in change in scope of consolidation fin cf | Prior1YTDDuration | -1346000000 | JPY |
| Payments from changes in ownership interests in subsidiaries that do not result in change in scope of consolidation fin cf | CurrentYTDDuration | - | JPY |
| Repayments of lease obligations fin cf | Prior1YTDDuration | -142000000 | JPY |
| Repayments of lease obligations fin cf | CurrentYTDDuration | -206000000 | JPY |
| Other net fin cf | Prior1YTDDuration | -0 | JPY |
| Other net fin cf | CurrentYTDDuration | -0 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -11850000000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -8869000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | -114000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | -495000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | -2376000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 1906000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 34884000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 35658000000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 32508000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 37564000000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -105000000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant | -111000000 | JPY |
| Payrolls and bonuses sga | Prior1YTDDuration | 5074000000 | JPY |
| Payrolls and bonuses sga | CurrentYTDDuration | 5817000000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 904000000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 964000000 | JPY |
| Research and development expenses sga | Prior1YTDDuration | 5305000000 | JPY |
| Research and development expenses sga | CurrentYTDDuration | 5820000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02349-000MedicalReportableSegmentsMember | 48369000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02349-000DeviceReportableSegmentsMember | 5972000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 54341000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Revenues from external customers | Prior1YTDDuration | 54341000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02349-000MedicalReportableSegmentsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02349-000DeviceReportableSegmentsMember | 6761000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 6761000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -6761000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | - | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02349-000MedicalReportableSegmentsMember | 48369000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02349-000DeviceReportableSegmentsMember | 12733000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 61103000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -6761000000 | JPY |
| Net sales | Prior1YTDDuration | 54341000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02349-000MedicalReportableSegmentsMember | 14026000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02349-000DeviceReportableSegmentsMember | 2875000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 16901000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -3403000000 | JPY |
| Operating income | Prior1YTDDuration | 13498000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02349-000MedicalReportableSegmentsMember | 55763000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02349-000DeviceReportableSegmentsMember | 5727000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |